SLNO — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

18.82

Margin Of Safety %

-42

Put/Call OI Ratio

1.2

EPS Next Q Diff

0.14

EPS Last/This Y

3.49

EPS This/Next Y

2.67

Price

52.36

Target Price

70.89

Analyst Recom

2.64

Performance Q

15.77

Upside

-85.3%

Beta

-2.78

Ticker: SLNO

16 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-03-09	SLNO	39.82	0.35	0.05	36226
2026-03-10	SLNO	40.62	0.35	0.01	36347
2026-03-11	SLNO	39.07	0.35	12.58	36437
2026-03-12	SLNO	36.78	0.35	1.21	36590
2026-03-13	SLNO	36.74	0.35	1.09	36590
2026-03-17	SLNO	33.63	0.69	8.60	47527
2026-03-18	SLNO	32.8	0.69	9.28	47495
2026-03-20	SLNO	33.21	0.78	0.22	53091
2026-03-25	SLNO	31.84	1.04	0.12	36820
2026-03-26	SLNO	31.67	1.02	3.43	37161
2026-03-27	SLNO	30.06	1.25	7.25	41379
2026-03-30	SLNO	30.47	1.41	0.06	45462
2026-03-31	SLNO	33.35	1.39	0.10	45797
2026-04-01	SLNO	36.96	1.28	0.15	47831
2026-04-06	SLNO	52.26	1.15	0.87	51162
2026-04-07	SLNO	52.3	1.20	0.74	89693
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

16 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-03-09	SLNO	39.81	-	-	3.99
2026-03-10	SLNO	40.62	-	-	3.99
2026-03-11	SLNO	39.07	-	-	3.99
2026-03-12	SLNO	36.75	-	-	4.04
2026-03-13	SLNO	33.75	-	-	4.04
2026-03-17	SLNO	33.64	-	-	4.04
2026-03-18	SLNO	32.80	-	-	4.04
2026-03-19	SLNO	33.63	-	-	4.04
2026-03-20	SLNO	33.22	-	-	3.89
2026-03-23	SLNO	31.74	-	-	3.89
2026-03-24	SLNO	31.31	-	-	3.89
2026-03-25	SLNO	31.85	-	-	3.89
2026-03-26	SLNO	31.84	-	-	3.89
2026-03-27	SLNO	30.06	-	-	3.89
2026-03-30	SLNO	30.46	-	-	3.89
2026-03-31	SLNO	33.47	-	-	3.89
2026-04-01	SLNO	36.97	-	-	3.89
2026-04-02	SLNO	39.49	-	-	3.89
2026-04-06	SLNO	52.26	-	-	3.89
2026-04-07	SLNO	52.36	-	-	3.89
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-03-09	SLNO	0.00	-1.27	19.57
2026-03-10	SLNO	0.00	-1.27	19.57
2026-03-11	SLNO	0.00	-1.27	17.89
2026-03-12	SLNO	0.00	-1.27	17.89
2026-03-13	SLNO	0.00	-1.27	17.89
2026-03-18	SLNO	0.00	-1.51	17.89
2026-03-19	SLNO	0.00	-1.51	17.89
2026-03-20	SLNO	0.00	-1.51	17.89
2026-03-23	SLNO	0.00	-1.40	17.89
2026-03-24	SLNO	0.00	-1.40	17.89
2026-03-25	SLNO	0.00	-1.40	18.82
2026-03-26	SLNO	0.00	-1.40	18.82
2026-03-27	SLNO	0.00	-1.40	18.82
2026-03-30	SLNO	0.00	-1.29	18.82
2026-03-31	SLNO	0.00	-1.29	18.82
2026-04-01	SLNO	-0.69	-1.29	18.82
2026-04-02	SLNO	-0.69	-1.29	18.82
2026-04-06	SLNO	-0.69	-0.39	18.82
2026-04-07	SLNO	-0.69	-0.39	18.82
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

0.8

Avg. EPS Est. Current Quarter

0.66

Avg. EPS Est. Next Quarter

0.94

Insider Transactions

-0.69

Institutional Transactions

-0.39

Beta

-2.78

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

113

Fair Value

30.54

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

-95.5

Target Price

70.89

P/E

234.86

Forward P/E

8.33

PEG

0.05

P/S

14.19

P/B

6.08

P/Free Cash Flow

57.92

EPS

0.22

Average EPS Est. Cur. Y

3.89

EPS Next Y. (Est.)

6.56

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

10.75

Relative Volume

6.74

Return on Equity vs Sector %

-22.9

Return on Equity vs Industry %

-6.4

EPS 1 7Days Diff

-0.2

EPS 1 30Days Diff

-0.32

EBIT Estimation

◆ SLNO Healthcare

$52.35

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

18/20

Pullback

8/25

Volume

0/15

Valuation

15/20

TP/AR

0/10

Options

4/10

RSI

77.9

Range 1M

99.5%

Sup Dist

0.4%

🚀

Momentum Growth

Ride accelerating trends

WEAK

Momentum

18/25

Growth

20/30

Estimates

3/20

Inst/Vol

5/15

Options

2/10

EPS Yr

912.4%

EPS NY

59.2%

52W%

37.5%

💎

Long-Term Value

Quality companies, undervalued

WATCH

🟢 BUY +163.9% upside

Quality

9/30

Valuation

19/30

Growth

17/25

Stability

8/10

LT Trend

2/5

Upside

+163.9%

Quality

MoS

-42%

Soleno Therapeutics, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 182

Soleno Therapeutics, Inc., biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is VYKAT XR, an extended-release tablets for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is headquartered in Redwood City, California.

SLNO

Latest News

—

Caricamento notizie per SLNO…

stock quote shares SLNO – Soleno Therapeutics Inc Stock Price stock today

news today SLNO – Soleno Therapeutics Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch SLNO – Soleno Therapeutics Inc yahoo finance google finance

stock history SLNO – Soleno Therapeutics Inc invest stock market

stock prices SLNO premarket after hours

ticker SLNO fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: SLNO

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y